BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 27395067)

  • 1. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
    Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does seronegative obstetric APS exist? "pro" and "cons".
    Conti F; Andreoli L; Crisafulli F; Mancuso S; Truglia S; Tektonidou MG
    Autoimmun Rev; 2019 Dec; 18(12):102407. PubMed ID: 31639518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; LLurba E; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Espinosa G; de Carolis S; Rovere-Querini P; Lundelin K; Picardo E; Mekinian A;
    Med Clin (Barc); 2018 Sep; 151(6):215-222. PubMed ID: 29274674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China.
    Zhou Z; Teng J; Sun Y; Liu H; Cheng X; Su Y; Yang C; Ye J
    Clin Rheumatol; 2019 Nov; 38(11):3161-3168. PubMed ID: 31290022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing antiphospholipid syndrome in pregnancy.
    Schreiber K; Hunt BJ
    Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications-a population-based study.
    Rhein AK; Rabinovich A; Abuhasira R; Lubaton-Barshishat S; Erez O
    Res Pract Thromb Haemost; 2024 May; 8(4):102430. PubMed ID: 38798792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current insights in obstetric antiphospholipid syndrome.
    Schreiber K; Radin M; Sciascia S
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
    J Thromb Haemost; 2023 Jul; 21(7):1981-1994. PubMed ID: 37061133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Hoxha A; Tincani A; Nalli C; Marozio L; Maina A; Espinosa G; Ríos-Garcés R; Cervera R; Carolis S; Monteleone G; Latino O; Udry S; LLurba E; Garrido-Gimenez C; Trespidi L; Gerosa M; Chighizola CB; Rovere-Querini P; Canti V; Mayer-Pickel K; Tabacco S; Arnau A; Trapé J; Ruiz-Hidalgo D; Sos L; Farran-Codina I;
    Rheumatology (Oxford); 2020 Jun; 59(6):1306-1314. PubMed ID: 31580459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
    Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
    De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
    Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics.
    Tonello M; Calligaro A; Favaro M; Del Ross T; Veronese P; Salvan E; Gervasi MT; Ruffatti A
    Arch Gynecol Obstet; 2021 Feb; 303(2):455-461. PubMed ID: 32880711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.
    Canti V; Del Rosso S; Tonello M; Lucianò R; Hoxha A; Coletto LA; Vaglio Tessitore I; Rosa S; Manfredi AA; Castiglioni MT; Ruffatti A; Rovere-Querini P
    J Rheumatol; 2018 Aug; 45(9):1263-1272. PubMed ID: 30008452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
    Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
    Front Immunol; 2018; 9():864. PubMed ID: 29867924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study.
    Jiang H; Wang CH; Jiang N; Li J; Wu CY; Wang Q; Li MT; Tian XP; Zhao JL; Zhao Y; Zeng XF
    Arthritis Res Ther; 2021 May; 23(1):138. PubMed ID: 33964976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study.
    Bouvier S; Cochery-Nouvellon E; Lavigne-Lissalde G; Mercier E; Marchetti T; Balducchi JP; Marès P; Gris JC
    Blood; 2014 Jan; 123(3):404-13. PubMed ID: 24200687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Tincani A; Marozio L; Espinosa G; Cervera R; Ríos-Garcés R; De Carolis S; Latino O; LLurba E; Chighizola CB; Gerosa M; Pengo V; Lundelin K; Rovere-Querini P; Canti V; Mayer-Pickel K; Reshetnyak T; Hoxha A; Tabacco S; Stojanovich L; Gogou V; Varoudis A; Arnau A; Ruiz-Hidalgo D; Trapé J; Sos L; Stoppani C; Martí-Cañamares A; Farran-Codina I;
    Autoimmun Rev; 2019 Apr; 18(4):406-414. PubMed ID: 30772493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for pregnancy morbidity in women with antiphospholipid syndrome.
    Yang J; Liang M
    J Reprod Immunol; 2021 Jun; 145():103315. PubMed ID: 33845396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.